Go Back

Company or ticker...

BioTech

argenx

Argenx is develops new antibody-based medicines to treat serious autoimmune diseases and cancer.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARGX

39.6B

10.7

37.3

-13.37%

Key Facts

M. Cap

PS

PE

YTD

39.6B

10.7

37.3

-13.37%

10MA

20MA

50MA

200MA

$ARGX

The Fullstack Investor

by Lin

v1.2

Join Now

Join Now

The Fullstack Investor

by Lin

v1.2

Join Now

Join Now

Join Now

Join Now